| Product Code: ETC6188555 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Pleurisy, an inflammation of the pleura, forms a subset of respiratory conditions addressed within Australias healthcare system. The market includes diagnostics, symptom management drugs, and supportive therapies. Seasonal respiratory infections and chronic diseases contribute to demand, with an emphasis on early intervention and effective pain management.
The pleurisy market in Australia is seeing gradual growth, mainly due to increasing respiratory infections and autoimmune disorders. Improved diagnostic capabilities are aiding earlier detection, while treatments focus on pain management and addressing the root causes. The market also benefits from heightened awareness and patient education about respiratory health, contributing to better disease management.
The pleurisy market struggles with underdiagnosis, as symptoms overlap with other respiratory conditions. Treatment largely remains symptomatic, with limited options to address the root causes directly. Patient awareness is low, affecting timely healthcare seeking behavior. The fluctuating incidence of pleurisy due to varying prevalence of infections and autoimmune diseases adds unpredictability to market demand.
The pleurisy market in Australia, focusing on inflammation of the pleura, presents investment potential primarily in drug development and diagnostic solutions. Opportunities exist in creating faster, more accurate diagnostic kits and effective anti-inflammatory medications. The rising burden of respiratory diseases linked to environmental factors provides a steady market base. Collaborations between pharmaceutical firms and research institutes can accelerate product innovation and commercialization.
The management of pleurisy in Australia is shaped by public health policies focused on respiratory diseases, with funding and awareness programs spearheaded by the Department of Health. Regulatory frameworks ensure access to diagnostic tools and medications through the Therapeutic Goods Administration (TGA) and public health insurance schemes, emphasizing early intervention and comprehensive care.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pleurisy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pleurisy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pleurisy Market - Industry Life Cycle |
3.4 Australia Pleurisy Market - Porter's Five Forces |
3.5 Australia Pleurisy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Pleurisy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Pleurisy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Australia |
4.2.2 Growing awareness about the symptoms and treatment options for pleurisy |
4.2.3 Technological advancements in diagnostic tools and treatment methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Australia |
4.3.2 Lack of skilled healthcare professionals specialized in treating pleurisy |
4.3.3 High cost associated with advanced treatment options for pleurisy |
5 Australia Pleurisy Market Trends |
6 Australia Pleurisy Market, By Types |
6.1 Australia Pleurisy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pleurisy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Pleurisy Market Revenues & Volume, By Thoracentesis, 2021- 2031F |
6.1.4 Australia Pleurisy Market Revenues & Volume, By Video-Assisted Thoracic Surgery, 2021- 2031F |
6.1.5 Australia Pleurisy Market Revenues & Volume, By Imaging Devices, 2021- 2031F |
6.1.6 Australia Pleurisy Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.2 Australia Pleurisy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Pleurisy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Australia Pleurisy Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Australia Pleurisy Market Revenues & Volume, By Diagnostics Laboratories, 2021- 2031F |
7 Australia Pleurisy Market Import-Export Trade Statistics |
7.1 Australia Pleurisy Market Export to Major Countries |
7.2 Australia Pleurisy Market Imports from Major Countries |
8 Australia Pleurisy Market Key Performance Indicators |
8.1 Average wait time for pleurisy diagnosis and treatment |
8.2 Percentage of patients receiving timely and appropriate care for pleurisy |
8.3 Adoption rate of new diagnostic tools and treatment methods for pleurisy |
9 Australia Pleurisy Market - Opportunity Assessment |
9.1 Australia Pleurisy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Pleurisy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Pleurisy Market - Competitive Landscape |
10.1 Australia Pleurisy Market Revenue Share, By Companies, 2024 |
10.2 Australia Pleurisy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |